SCHEMBL7769428

SCHEMBL7769428

Cc1nc(S)[nH]c1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
HPGD P15428 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 4/20 0.41
L3MBTL1 Q9Y468 4/20 0.41
LMNA P02545 1/20 0.41
MDM2 Q00987 2/20 0.39
GAA P10253 2/20 0.39
PLA2G10 O15496 1/20 0.39
HSD17B10 Q99714 1/20 0.39
POLB P06746 1/20 0.38
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
CHEK1 O14757 1/20 0.37
AKT2 P31751 1/20 0.37
MAPT P10636 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1116552 0.80 CYP11B1 (0.54) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL5850257 0.79 KDM4E (0.68) KDM4EHPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL1172425 0.78 KDM4E (0.60) KDM4EHPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL11516210 0.78 MAPK13 (0.53) KDM4EHPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL16868394 0.76 KDM4E (0.48) KDM4EHPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL1980159 0.76 XDH (0.50) KDM4EHPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL7769423 0.73 KDM4E (0.69) KDM4EHPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL4111920 0.73 KDM4E (0.69) KDM4EHPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL19116734 0.73 L3MBTL1 (0.61) KDM4EHPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL23758282 0.72 GAA (0.58) KDM4EHPGDSMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1112072-A2 METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES Sentron Medical, Inc. (US) 2001-07-04 EP disclosed
WO-2000015768-A9 IMMUNE ACTIVATION BY DOUBLE-STRANDED POLYNUCLEOTIDES KOHN LEONARD D (US) 2000-08-31 WO disclosed
WO-2000012175-A2 METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES SENTRON MEDICAL, INC. (US) 2000-03-09 WO disclosed